Optimized Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia

计划入组 58 人 · 首次发布于 2024 年 9 月 23 日

Study on Water Vapor Thermal Therapy

计划入组 300 人 · 首次发布于 2024 年 10 月 24 日

One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia.

计划入组 71 人 · 首次发布于 2024 年 2 月 14 日

Water(Activase, Alphanate, Alphanine Sd, Eye Stream, Hiberix, Koate, Nuwiq, Profilnine, Prolastin, Serostim, Thrombate III)

<dd class="col-xl-8 col-md-9 col-sm-8">H₂O</dd>

Water-soluble Taxanes

Water-soluble Vitamin

Rx

R. J. Reynolds Vapor Company

United States

Water Pik, Inc.

United States

ESSENTIA WATER, LLC

United States

Modified Water Vapor Therapy Shows Promise for Large-Volume Benign Prostatic Hyperplasia Treatment

VAPOR 2 Trial Completes Enrollment: Testing Novel Water Vapor Ablation Device for Prostate Cancer

UroLift System Demonstrates Superior Patient Outcomes in Head-to-Head BPH Treatment Trials